MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹306 Cr | ₹207 Cr | ₹493 Cr | ₹670 Cr | ₹372 Cr |
What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?
Year | Capital Work in Progress |
---|---|
Mar2025 | ₹306 Cr |
Mar2024 | ₹207 Cr |
Mar2023 | ₹493 Cr |
Mar2022 | ₹670 Cr |
Mar2021 | ₹372 Cr |
How is Capital Work in Progress of MANKIND PHARMA Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2025 | ₹306 Cr | 47.82 | |
Mar2024 | ₹207 Cr | -58.01 | |
Mar2023 | ₹493 Cr | -26.38 | |
Mar2022 | ₹670 Cr | 80.26 | |
Mar2021 | ₹372 Cr | - |
Compare Capital Work in Progress of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹109,846.1 Cr | 3% | 6.2% | 7.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 3% |
6.2% |
7.5% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses